Genetics

Chemical Immunology and Allergy

Volumn 84, Issue , 2004, Pages 1-35

  Holloway, John W ^a,b   Holgate, Stephen T ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CD14 ANTIGEN; GLUCOCORTICOID; HLA ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; LEUKOTRIENE C4 SYNTHASE; LIPOXYGENASE INHIBITOR; SALBUTAMOL; STEROID; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ATOPY; CHROMOSOME 11Q; CHROMOSOME 12; CHROMOSOME 5Q; DISEASE PREDISPOSITION; DISEASE SEVERITY; GENETIC REGULATION; GENETIC SCREENING; HERITABILITY; HISTORY OF MEDICINE; HUMAN; NOMENCLATURE; PHARMACOGENOMICS; PRIORITY JOURNAL; REVIEW;

EID: 6044244681     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000081548     Document Type: Review

References (199)

1. Coca A, Cooke R: On the classification of the phenomena of hypersensitiveness. J Immunol 1923;8:163-180. (NC)
2. Johansson SG, Hourihane JO, Bousquet J, et al: A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813-824. (NC)
3. Johansson SG, Bieber T, Dahl R: Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832-836.
4. Lawrence S, Beasley R, Doull I, et al: Genetic analysis of atopy and asthma as quantitative traits and ordered polychotomies. Ann Hum Genet 1994;58:359-368. (NC)
5. Wilkinson J, Grimley S, Collins A, et al: Linkage of asthma to markers on chromosome 12 in a sample of 240 families using quantitative phenotype scores. Genomics 1998;53:251-259. (III)
6. Cooke RA, van der Veer A: Human sensitisation. J Immunol 1916;16:201-305. (III)
7. Hayashi T, Kawakami N, Kondo N, et al: Prevalence of and risk factors for allergic diseases - Comparison of two cities in Japan. Ann Allergy 1995;75(6 pt 1):525-529. (III)
8. Bazaral M, Orgel HA, Hamburger RN: IgE levels in normal infants and mothers and an inheritance hypothesis. J Immunol 1971;107:794-801. (NC)
9. Gerrard JW, Vickers P, Gerrard CD: The familial incidence of allergic disease. Ann Allergy 1976;36:10-15. (III)
10. Dold S, Wjst M, von Mutius E, et al: Genetic risk for asthma, allergic rhinitis, and atopic dermatitis. Arch Dis Child 1992;67:1018-1022. (III)
11. von Mutius E, Nicolai T: Familial aggregation of asthma in a South Bavarian population. Am J Respir Crit Care Med 1996;153(4 pt 1):1266-1272. (III)
12. Duffy DL, Martin NG, Battistutta D, et al: Genetics of asthma and hay fever in Australian twins. Am Rev Respir Dis 1990;142(6 pt 1):1351-1358. (III)
13. Wuthrich B, Baumann E, Fries RA, et al: Total and specific IgE (RAST) in atopic twins. Clin Allergy 1981;11:147-154. (III)
14. Husby S, Holm NV, Christensen K, et al: Cord blood immunoglobulin E in like-sexed monozygotic and dizygotic twins. Clin Genet 1996;50:332-338. (III)
15. Sarafino EP, Goldfedder J: Genetic-factors in the presence, severity, and triggers of asthma. Arch Dis Child 1995;73:112-116. (III)
16. Hopp RJ, Bewtra AK, Watt GD, et al: Genetic analysis of allergic disease in twins. J Allergy Clin Immunol 1984;73:265-270. (III)
17. Harris JR, Magnus P, Samuelsen SO, et al: No evidence for effects of family environment on asthma. A retrospective study of Norwegian twins. Am J Respir Crit Care Med 1997;156:43-49. (III)
18. Hanson B, McGue M, Roitman-Johnson B, et al: Atopic disease and immunoglobulin E in twins reared apart and together. Am J Hum Genet 1991;48:873-879. (III)
19. Sibbald B, Horn ME, Gregg I: A family study of the genetic basis of asthma and wheezy bronchitis. Arch Dis Child 1980;55:354-357. (III)
20. Sibbald B, Turner-Warwick M: Factors influencing the prevalence of asthma among first degree relatives of extrinsic and intrinsic asthmatics. Thorax 1979;34:332-337. (III)
21. Longo G, Strinati R, Poli F, et al: Genetic factors in nonspecific bronchial hyperreactivity. An epidemiologic study. Am J Dis Child 1987;141:331-334. (III)
22. Laitinen T, Rasanen M, Kaprio J, et al: Importance of genetic factors in adolescent asthma - A population-based twin-family study. Am J Respir Crit Care Med 1998;157:1073-1078. (III)
23. Skadhauge LR, Christensen K, Kyvik KO, et al: Genetic and environmental influence on asthma: A population-based study of 11,688 Danish twin pairs. Eur Respir J 1999;13:8-14. (III)
24. Blumenthal MN, Namboodiri K, Mendell N, et al: Genetic transmission of serum IgE levels. Am J Med Genet 1981;10:219-228. (III)
25. Dizier MH, Hill M, James A, et al: Detection of a recessive major gene for high IgE levels acting independently of specific response to allergens. Genet Epidemiol 1995;12:93-105. (III)
26. Gerrard JW, Rao DC, Morton NE: A genetic study of immunoglobulin E. Am J Hum Genet 1978;30:46-58. (III)
27. Hasstedt SJ, Meyers DA, Marsh DG: Inheritance of immunoglobulin E: Genetic model fitting. Am J Med Genet 1983;14:61-66. (III)
28. Meyers DA, Beaty TH, Freidhoff LR, et al: Inheritance of total serum IgE (basal levels) in man. Am J Hum Genet 1987;41:51-62. (III)
29. Meyers DA, Beaty TH, Colyer CR, et al: Genetics of total serum IgE levels: A regressive model approach segregation analysis. Genet Epidemiol 1991;8:351-359. (III)
30. Meyers DA, Postma DS, Panhuysen C, et al: Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics 1994;23:464-470. (III)
31. Hopp RJ, Bewtra AK, Biven R, et al: Bronchial reactivity pattern in nonasthmatic parents of asthmatics. Ann Allergy 1988;61:184-186. (III)
32. Konig P, Godfrey S: Prevalence of exercise-induced bronchial lability in families of children with asthma. Arch Dis Child 1973;48:513-518. (III)
33. Townley RG, Bewtra A, Wilson AF, et al: Segregation analysis of bronchial response to methacholine inhalation challenge in families with and without asthma. J Allergy Clin Immunol 1986;77(1 pt 1):101-107. (III)
34. Martinez FD, Holberg CJ, Halonen M, et al: Evidence for Mendelian inheritance of serum IgE levels in Hispanic and non-Hispanic white families. Am J Hum Genet 1994;55:555-565. (III)
35. Spielman RS, Ewens WJ: The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996;59:983-999. (NC)
36. Daniels SE, Bhattacharrya S, James A, et al: A genome-wide search for quantitative trait loci underlying asthma. Nature 1996;383:247-250. (III)
37. Wiltshire S, Bhattacharyya S, Faux JA, et al: A genome scan for loci influencing total serum immunoglobulin levels: Possible linkage of IgA to the chromosome 13 atopy locus. Hum Mol Genet 1998;7:27-31. (III)
38. Collaborative Study on the Genetics of Asthma: A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat Genet 1997;15:389-392. (III)
39. Xu J, Meyers DA, Ober C, et al: Genomewide screen and identification of gene-gene interactions for asthma-susceptibility loci in three U.S. populations: Collaborative study on the genetics of asthma. Am J Hum Genet 2001;1437-1446. (III)
40. Wjst M, Fischer G, Immervoll T, et al: A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics 1999;58:1-8. (III)
41. Dizier MH, Besse-Schmittler C, Guilloud-Bataille M, et al: Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med 2000;162:1812-1818. (III)
42. Ober C, Cox NJ, Abney M, et al: Genome-wide search for asthma susceptibility loci in a founder population. Hum Mol Genet 1998;7:1393-1398. (III)
43. Laitinen T, Daly MJ, Rioux JD, et al: A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population. Nat Genet 2001;28:87-91. (III)
44. Zamel N, McClean PA, Sandell PR, et al: Asthma on Tristan da Cunha - Looking for the genetic link. The University of Toronto Genetics of Asthma Research Group. Am J Respir Crit Care Med 1996;153(6 pt 1):1902-1906. (NC)
45. Brooks-Wilson AR, Buckler A, Cardon L, et al: Asthma related genes. US Patent & Trademark Office 6,087,485. South San Francisco, AxyS Pharmaceuticals, 2000. (NC)
46. Tugores A, Le J, Sorokina I, et al: The epithelium-specific ETS protein EHF/ESE-3 is a context-dependent transcriptional repressor downstream of MAPK signaling cascades. J Biol Chem 2001;276:20397-20406. (NC)
47. Lee YA, Wahn U, Kehrt R, et al: A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet 2000;26:470-473. (III)
48. Cookson WOCM, Ubhi B, Lawrence R, et al: Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 2001;27:372-373. (III)
49. Haagerup A, Bjerke T, Schoitz PO, et al: Allergic rhinitis - A total genome-scan for susceptibility genes suggests a locus on chromosome 4q24-q27. Eur J Hum Genet 2001;9:945-952. (III)
50. Zhang Y, Leaves NI, Anderson GG, et al: Positional cloning of a quantitative trait locus on chromosome 13q14 that influences immunoglobulin E levels and asthma. Nat Genet 2003;34: 181-186. (IIb)
51. Allen M, Heinzmann A, Noguchi E, et al: Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat Genet 2003;35:258-263. (IIb)
52. Van Eerdewegh P, Little RD, Dupuis J, et al: Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002;418:426-430. (IIb)
53. Howard TD, Postma DS, Jongepier H, et al: Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. J Allergy Clin Immunol 2003; 112:717-722. (III)
54. Werner M, Herbon N, Gohlke H, et al: Asthma is associated with single-nucleotide polymorphisms in ADAM33. Clin Exp Allergy 2004;34:26-31. (III)
55. Lind DL, Choudhry S, Ung N, et al: ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. Am J Respir Crit Care Med 2003;168:1312-1316. (III)
56. Hysi PG, Cantelmo JL, Moffatt MF, et al: Absence of association of the ADAM33 polymorphism with asthma in two British panels. Am J Respir Crit Care Med 2003;17:A440. (NC)
57. Yoshinaka T, Nishii K, Yamada K, et al: Identification and characterization of novel mouse and human ADAM33s with potential metalloprotease activity. Gene 2002;282:227-236. (NC)
58. Primakoff P, Myles DG: The ADAM gene family: Surface proteins with adhesion and protease activity. Trends Genet 2000;16:83-87. (NC)
59. Black RA, White JM: ADAMs: Focus on the protease domain. Curr Opin Cell Biol 1998;10: 654-659. (NC)
60. Holgate ST, Lackie PM, Howarth PH, et al: Activation of the epithelial mesenchymal trophic unit in the pathogenesis of asthma. Int Arch Allergy Immunol 2001;124:253-258. (NC)
61. Richter A, Puddicombe SM, Lordan JL, et al: The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. Am J Respir Cell Mol Biol 2001;25:385-391. (NC)
62. Yagami-Hiromasa T, Sato T, Kurisaki T, et al: A metalloprotease- disintegrin participating in myoblast fusion. Nature 1995;377:652-656. (NC)
63. Kimura K, Noguchi E, Shibasaki M, et al: Linkage and association of atopic asthma to markers on chromosome 13 in the Japanese population. Hum Mol Genet 1999;8:1487-1490. (III)
64. Hizawa N, Freidhoff LR, Chiu YF, et al: Genetic regulation of Dermatophagoides pteronyssinus-specific IgE responsiveness: A genome-wide multipoint linkage analysis in families recruited through 2 asthmatic sibs. J Allergy Clin Immunol 1998;102:436-442. (III)
65. Bhattacharyya S, Leaves NI, Wiltshire S, et al: A high-density genetic map of the chromosome 13q14 atopy locus. Genomics 2000;70:286-291. (NC)
66. Anderson GG, Leaves NI, Bhattacharyya S, et al: Positive association to IgE levels and a physical map of the 13q14 atopy locus. Eur J Hum Genet 2002;10:266-270. (III)
67. Wjst M, Immervoll T: An internet linkage and mutation database for the complex phenotype asthma. Bioinformatics 1998;14:827-828. (NC)
68. Weiss ST: Association studies in asthma genetics. Am J Respir Crit Care Med 2001;164: 2014-2015. (NC)
69. Hall I: Candidate gene studies in respiratory disease: Avoiding the pitfalls. Thorax 2002;57: 377-378. (NC)
70. Tabor HK, Risch NJ, Myers RM: Candidate gene approaches for studying complex genetic traits: Practical considerations. Nat Rev Genet 2002;3:391-397. (NC)
71. Cookson WO, Sharp PA, Faux JA, et al: Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1989;i:1292-1295. (III)
72. Young RP, Sharp PA, Lynch JR, et al: Confirmation of genetic linkage between atopic IgE responses and chromosome 11q13. J Med Genet 1992;29:236-238. (III)
73. Cookson WO, Young RP, Sandford AJ, et al: Maternal inheritance of atopic IgE responsiveness on chromosome 11q. Lancet 1992;340:381-384. (III)
74. Sandford AJ, Shirakawa T, Moffatt MF, et al: Localisation of atopy and beta subunit of high-affinity IgE (FcεRI) on chromosome 11q. Lancet 1993;341:332-334. (III)
75. Palmer LJ, Daniels SE, Rye PJ, et al: Linkage of chromosome 5q and 11q gene markers to asthma-associated quantitative traits in Australian children. Am J Respir Crit Care Med 1998;158: 1825-1830. (III)
76. Hizawa N, Yamaguchi E, Ohe M, et al: Lack of linkage between atopy and locus 11q13. Clin Exp Allergy 1992;22:1065-1069. (III)
77. Lympany P, Welsh K, MacCochrane G, et al: Genetic analysis using DNA polymorphism of the linkage between chromosome 11q13 and atopy and bronchial hyperresponsiveness to methacholine. J Allergy Clin Immunol 1992;89:619-628. (III)
78. Rich SS, Roitman JB, Greenberg B, et al: Genetic analysis of atopy in three large kindreds: No evidence linkage to D11S97. Clin Exp Allergy 1992;22:1070-1076. (III)
79. Coleman R, Trembath RC, Harper JI: Chromosome 11q13 and atopy underlying atopic eczema. Lancet 1993;341:1121-1122. (III)
80. Amelung PJ, Panhuysen CI, Postma DS, et al: Atopy and bronchial hyperresponsiveness: Exclusion of linkage markers on chromosomes 11q and 6p. Clin Exp Allergy 1992;22:1077-1084. (III)
81. Collee JM, ten Kate LP, de Vries HG, et al: Allele sharing on chromosome 11q13 in sibs with asthma and atopy. Lancet 1993;342:936. (III)
82. Hizawa N, Yamaguchi E, Furuya K, et al: Association between high serum total IgE levels and D11S97 on chromosome 11q13 in Japanese subjects. J Med Genet 1995;32:363-369. (III)
83. Amelung PJ, Postma DS, Xu J, et al: Exclusion of chromosome 11q and the FcεRI-β gene as aetiological factors in allergy and asthma in a population of Dutch asthmatic families. Clin Exp Allergy 1998;28:397-403. (III)
84. Folster Holst R, Moises HW, Yang L, et al: Linkage between atopy and the IgE high-affinity receptor gene at 11q13 in atopic dermatitis families. Hum Genet 1998;102:236-239. (III)
85. Scharenberg AM, Kinet JP: Fc epsilon RI and the FcR-beta amplifier. Int Arch Allergy Immunol 1997;113:42-44. (NC)
86. Shirakawa T, Hashimoto T, Furuyama J, et al: Linkage between severe atopy and chromosome 11q13 in Japanese families. Clin Genet 1994;46:228-232. (III)
87. Hill MR, James AL, Faux JA, et al: FcεRI-β polymorphism and risk of atopy in a general population sample. BMJ 1995;311:776-779. (III)
88. Li A, Hopkin J: Atopy phenotype in subjects with variants of the beta subunit of the high affinity IgE receptor. Thorax 1997;52:654-655. (III)
89. Thomas NS, Holgate ST: Genes for asthma on chromosome 11: An update. Clin Exp Allergy 1998;28:387-391. (NC)
90. Li AR, Mackay GA, Hopkin JM: Functional analysis of histamine release from basophils and mast cells in subjects with the Ile-181->Leu variant of Fc epsilon RI-beta. Clin Sci 1997;93:279-286. (NC)
91. Hill MR, Cookson WOCM: A new variant of the β subunit of the high-affinity receptor for immunoglobulin E (FcεRIβE237G) - Associations with measures of atopy and bronchial hyperresponsiveness. Hum Mol Genet 1996;5:959-962. (III)
92. Shirakawa T, Mao XQ, Sasaki S, et al: Association between atopic asthma and a coding variant of FcεRI-β in a Japanese population. Hum Mol Genet 1996;5:1129-1130. (III)
93. Palmer LJ, Pare PD, Faux JA, et al: FcεRI-β polymorphism and total serum IgE levels in endemically parasitized Australian aborigines. Am J Hum Genet 1997;61:182-188. (III)
94. Trabetti E, Cusin V, Malerba G, et al: Association of the FcεRIβ gene with bronchial hyperresponsiveness in an Italian population. J Med Genet 1998;35:680-681. (III)
95. Fukao T, Kaneko H, Teramoto T, et al: Association between FcεRI β and atopic disorder in Japanese population? Lancet 1996;348:407. (NC)
96. Castro J, Telleria JJ, Blanco-Quiros A, et al: Lack of association between atopy and RsaI polymorphism within intron 2 of the Fc(epsilon)RI-beta gene in a Spanish population sample. Allergy 1998;53:1083-1086. (III)
97. Cox HE, Moffatt MF, Faux JA, et al: Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor. Br J Dermatol 1998;138:182-187. (III)
98. Hay JG, Danel C, Chu CS, et al: Human CC10 gene expression in airway epithelium and subchromosomal locus suggest linkage to airway disease. Am J Physiol 1995;268(4 pt 1):L565-L575. (NC)
99. Laing IA, Goldblatt J, Eber E, et al: A polymorphism of the CC16 gene is associated with an increased risk of asthma. J Med Genet 1998;35:463-467. (III)
100. Gao PS, Mao XQ, Kawai M, et al: Negative association between asthma and variants of CC16(CC10) on chromosome 11q13 in British and Japanese populations. Hum Genet 1998;103:57-59. (III)
101. Mao XQ, Shirakawa T, Kawai M, et al: Association between asthma and an intragenic variant of CC16 on chromosome 11q13. Clin Genet 1998;53:54-56. (III)
102. Marsh DG, Neely JD, Breazeale DR, et al: Linkage analysis of IL4 and other chromosome 5q31.1 total serum immunoglobulin E concentrations. Science 1994;264:1152-1156. (III)
103. Xu J, Levitt RC, Panhuysen C, et al: Evidence for two unlinked loci regulating total serum IgE levels. Am J Hum Genet 1995;57:425-430. (III)
104. Postma DS, Bleecker ER, Amelung PJ, et al: Genetic susceptibility to asthma - Bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995;333:894-900. (III)
105. Doull IJM, Lawrence S, Watson M, et al: Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness. Am J Respir Crit Care Med 1996;153(4 pt 1):1280-1284. (III)
106. Noguchi E, Shibasaki M, Arinami T, et al: Evidence for linkage between asthma/atopy in childhood and chromosome 5q31-q33 in a Japanese population. Am J Respir Crit Care Med 1997;156:1390-1393. (III)
107. Walley AJ, Wiltshire S, Ellis CM, et al: Linkage and allelic association of chromosome 5 cytokine cluster genetic markers with atopy and asthma associated traits. Genomics 2001;72:15-20. (III)
108. Blumenthal MN, Wang Z, Weber JL, et al: Absence of linkage between 5q markers and serum IgE levels in four large atopic families. Clin Exp Allergy 1996;26:892-896. (III)
109. Kamitani A, Wong ZYH, Dickson P, et al: Absence of genetic linkage of chromosome 5q31 with asthma and atopy in the general population. Thorax 1997;52:816-817. (III)
110. Laitinen T, Kauppi P, Ignatius J, et al: Genetic control of serum IgE levels and asthma: Linkage and linkage disequilibrium studies in an isolated population. Hum Mol Genet 1997;6:2069-2076. (III)
111. Mansur AH, Bishop DT, Markham AF, et al: Association study of asthma and atopy traits and chromosome 5q cytokine cluster markers. Clin Exp Allergy 1998;28:141-150. (III)
112. Palmer LJ, Lonjou C, Barnes K, et al: Special Report: A retrospective collaboration on chromosome 5 by the International Consortium on Asthma Genetics (COAG). Clin Exp Allergy 2001;31:152-154. (NC)
113. Lonjou C, Barnes K, Chen H, et al: A first trial of retrospective collaboration for positional cloning in complex inheritance: Assay of the cytokine region on chromosome 5 by the Consortium on Asthma Genetics (COAG). Proc Natl Acad Sci USA 2000;97:10942-10947. (III)
114. Rosenwasser LJ, Klemm DJ, Dresback JK, et al: Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995;25(suppl 2):74-78. (NC)
115. Walley AJ, Cookson WOCM: Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy. J Med Genet 1996;33:689-692. (III)
116. Noguchi E, Shibasaki M, Arinami T, et al: Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy 1998;28:449-453. (III)
117. Burchard EG, Silverman EK, Rosenwasser LJ, et al: Association between a sequence variant in the IL-4 gene promoter and FEV(1) in asthma. Am J Respir Crit Care Med 1999;160:919-922. (III)
118. Kawashima T, Noguchi E, Arinami T, et al: Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet 1998;35:502-504. (III)
119. Ohara J, Paul WE: Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage. Nature 1987;325:537-540. (NC)
120. Idzerda RL, March CJ, Mosley B, et al: Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 1990;171:861-873. (III)
121. Pritchard MA, Baker E, Whitmore SA, et al: The interleukin-4 receptor gene (IL4R) maps to 16p11.2-16p12.1 in human and to the distal region of mouse chromosome 7. Genomics 1991;10:801-806. (III)
122. Deichmann KA, Heinzmann A, Forster J, et al: Linkage and allelic association of atopy and markers flanking the IL4-receptor gene. Clin Exp Allergy 1998;28:151-155. (III)
123. Deichmann K, Bardutzky J, Forster J, et al: Common polymorphisms in the coding part of the IL4-receptor gene. Biochem Biophys Res Commun 1997;231:696-697. (NC)
124. Mitsuyasu H, Izuhara K, Mao XQ, et al: Ile50Val variant of IL4Rα upregulates IgE synthesis and associates with atopic asthma. Nat Genet 1998;19:119-120. (III)
125. Mitsuyasu H, Yanagihara Y, Mao XQ, et al: Dominant effect of Ile50Val variant of the human IL-4 receptor α-chain in IgE synthesis. J Immunol 1999;162:1227-1231. (NC)
126. Noguchi E, Shibasaki M, Arinami T, et al: No association between atopy/asthma and the ILe50Val polymorphism of IL-4 receptor. Am J Respir Crit Care Med 1999;160:342-345. (III)
127. Hershey GKK, Friedrich MF, Esswein LA, et al: The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 1997;337:1720-1725. (NC)
128. Wang HY, Shelburne CP, Zamorano J, et al: Effects of an allergy-associated mutation in the human IL-4Rα (Q576R) on human IL-4-induced signal transduction. J Immunol 1999;162:4385-4389. (NC)
129. Ober C, Leavitt SA, Tsalenko A, et al: Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am J Hum Genet 2000;66:517-526. (III)
130. Grunig G, Warnock M, Wakil AE, et al: Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998;282:2261-2263. (NC)
131. Wills-Karp M, Luyimbazi J, Xu X, et al: Interleukin-13: Central mediator of allergic asthma. Science 1998;282:2258-2261. (NC)
132. Zhu Z, Homer RJ, Wang Z, et al: Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-788. (NC)
133. Frazer KA, Ueda Y, Zhu Y, et al: Computational and biological analysis of 680 kb of DNA sequence from the human 5q31 cytokine gene cluster region. Genome Res 1997;7:495-512. (NC)
134. van der Pouw Kraan T, van Veen A, Boeije L, et al: An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun 1999;1:61-65. (III)
135. Graves PE, Kabesch M, Halonen M, et al: A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000;105:506-513. (III)
136. Heinzmann A, Mao XQ, Akaiwa M, et al: Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 2000;9:549-559. (III)
137. Pantelidis P, Jones MG, Welsh KI, et al: Identification of four novel interleukin-13 gene polymorphisms. Genes Immun 2000;1:341-345. (NC)
138. Liu X, Nickel R, Beyer K, et al: An IL 13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol 2000;106(1 pt 1):167-170. (III)
139. Howard TD, Whittaker PA, Zaiman AL, et al: Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol 2001;25:377-384. (III)
140. Noguchi E, Nukaga-Nishio Y, Jian Z, et al: Haplotypes of the 5′ region of the IL-4 gene and SNPs in the intergene sequence between the IL-4 and IL-13 genes are associated with atopic asthma. Hum Immunol 2001;62:1251-1257. (III)
141. Loots GG, Locksley RM, Blankespoor CM, et al: Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 2000;288:136-140. (NC)
142. 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993;8:334-339. (III)
143. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994;33:9414-9419. (NC)
144. 2- adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995;13:25-33. (NC)
145. 2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. J Allergy Clin Immunol 1997;100:261-265. (III)
146. D'Amato M, Vitiani LR, Petrelli G, et al: Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study. Am J Respir Crit Care Med 1998;158:1968-1973. (III)
147. 2-Adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population. Clin Exp Allergy 1998;28:442-448. (III)
148. 2-adrenoceptor with reported childhood asthma: Population based study. BMJ 1998;316:664. (III)
149. Ramsay CE, Hayden CM, Tiller KJ, et al: Polymorphisms in the beta2-adrenoreceptor gene are associated with decreased airway responsiveness. Clin Exp Allergy 1999;29:1195-1203. (III)
150. 2-adrenoceptor polymorphisms and enhanced IgE responsiveness in an atopic population. Clin Exp Allergy 1999;29:794-799. (III)
151. Wang Z, Chen C, Niu T, et al: Association of asthma with beta(2)-adrenergic receptor gene polymorphism and cigarette smoking. Am J Respir Crit Care Med 2001;163:1404-1409. (III)
152. Barr RG, Cooper DM, Speizer FE, et al: Beta(2)-adrenoceptor polymorphism and body mass index are associated with adult-onset asthma in sedentary but not active women. Chest 2001;120:1474-1479. (III)
153. Baldini M, Lohman IC, Halonen M, et al: A Polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999;20:976-983. (III)
154. Koppelman GH, Reijmerink NE, Colin Stine O, et al: Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med 2001;163:965-969. (III)
155. Yang IA, Barton SJ, Rorke S, et al: Toll-like receptor 4 polymorphism and severity of atopy in asthmatics. Genes Immun 2004;5:41-45. (III)
156. Werner M, Topp R, Wimmer K, et al: TLR4 gene variants modify endotoxin effects on asthma. J Allergy Clin Immunol 2003;112:323-330. (III)
157. Vercelli D: Learning from discrepancies: CD14 polymorphisms, atopy and the endotoxin switch. Clin Exp Allergy 2003;33:153-155. (NC)
158. Chavanas S, Garner C, Bodemer C, et al: Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping. Am J Hum Genet 2000;66:914-921. (NC)
159. Walley AJ, Chavanas S, Moffatt MF, et al: Gene polymorphism in Netherton and common atopic disease. Nat Genet 2001;29:175-178. (III)
160. Barnes KC, Neely JD, Duffy DL, et al: Linkage of asthma and total serum IgE concentration to markers on chromosome 12q - Evidence from Afro-Caribbean and Caucasian populations. Genomics 1996;37:41-50. (III)
161. Nickel R. Wahn U, Hizawa N, et al: Evidence for linkage of chromosome 12q15-q24.1 markers to high total serum IgE concentrations in children of the German Multicenter Allergy Study. Genomics 1997;46:159-162. (III)
162. Marsh DG, Hsu SH, Roebber M, et al: HLA-Dw2: A genetic marker for human immune response to short ragweed pollen allergen Ra5. I. Response resulting primarily from natural antigenic exposure. J Exp Med 1982;155:1439-1451. (III)
163. Marsh DG, Blumenthal MN, Ishikawa T, et al: HLA and specific immune responsiveness to allergens; in Tsuji K, Aizawa M, Sasazuki T (eds): HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford, Oxford University Press, 1992, pp 765-771. (III)
164. Blumenthal M, Marcus BD, Awdeh Z, et al: HLA-DR2, [HLA-B7, SC31, DR2], and [HLA-B8, SC01, DR3] distinguish subjects with asthma from those with rhinitis only ragweed pollen allergy. J Immunol 1992;148:411-416. (III)
165. Aron Y, Swierczewski E, Lockhart A: A simple and rapid micromethod for genomic DNA extraction from jugal epithelial cells. Application to human lymphocyte antigen typing in one large family of atopic/asthmatic probands. Allergy 1994;49:788-790. (NC)
166. Aron Y, Desmazesdufeu N, Matran R, et al Evidence of a strong, positive association between atopy and the HLA class II alleles DR4 and DR7. Clin Exp Allergy 1996;26:821-828. (III)
167. Holloway J, Doull I, Begishvili B, et al: Lack of evidence of a significant association between HLA-DR, DQ and DP genotypes and atopy in families with HDM allergy. Clin Exp Allergy 1996;26:1142-1149. (III)
168. Young RP, Dekker JW, Wordsworth BP, et al: HLA-DR and HLA-DP genotypes and immunoglobulin E responses to common major allergens. Clin Exp Allergy 1994;24:431-439. (III)
169. Hizawa N, Collins G, Rafnar T, et al: Linkage analysis of Dermatophagoides pteronyssinus-specific IgE responsiveness with polymorphic markers on chromosome 6p21 (HLA-D region) in Caucasian families by the transmission/disequilibrium test. J Allergy Clin Immunol 1998;102:443-448. (III)
170. Hizawa N, Freidhoff LR, Ehrlich E, et al: Genetic influences of chromosomes 5q31-q33 and 11q13 on specific IgE responsiveness to common inhaled allergens among African American families. J Allergy Clin Immunol 1998;102:449-453. (III)
171. Moffatt MF, Hill MR, Cornells F, et al: Genetic linkage of T-cell receptor α/δ complex to specific IgE responses. Lancet 1994;343:1597-1600. (III)
172. Noguchi E, Shibasaki M, Arinami T, et al: Evidence for linkage between the development of asthma in childhood and the T-cell receptor β chain gene in Japanese. Genomics 1998;47:121-124. (III)
173. Houlston RS, Tomlinson IP: Modifier genes in humans: Strategies for identification. Eur J Hum Genet 1998;6:80-88. (NC)
174. Quinn M, Angelico MC, Warram JH, et al: Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996;39:940-945. (NC)
175. Sarafino EP: Connections among parent and child atopic illnesses. Pediatr Allergy Immunol 2000;11:80-86. (III)
176. Gray L, Peat JK, Belousova E, et al: Family patterns of asthma, atopy and airway hyperresponsiveness: An epidemiological study. Clin Exp Allergy 2000;30:393-399. (III)
177. Wilson NM, Dore CJ, Silverman M: Factors relating to the severity of symptoms at 5 yrs in children with severe wheeze in the first 2 yrs of life. Eur Respir J 1997;10:346-353. (III)
178. Chagani T, Paré P, Wier T, et al: TNFα and IL-4 promoter polymorphisms and asthma. Am J Respir Crit Care Med 1998;157:A875. (III)
179. Sandford AJ, Chagani T, Zhu S, et al: Polymorphisms in the IL4, IL4RA, and FCεRIβ genes and asthma severity. J Allergy Clin Immunol 2000;106:135-140. (III)
180. Turki J, Pak J, Green SA, et al: Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly 16 correlates with the nocturnal phenotype. J Clin Invest 1995;95:1635-1641. (III)
181. Palmer LJ, Silverman ES, Weiss ST, et al: Pharmacogenetics of asthma. Am J Respir Crit Care Med 2002;165:861-866. (NC)
182. 2- adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet 1997;350: 995-999. (III)
183. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997;100:3184-3188. (III)
184. Lipworth BJ, Hall IP, Tan S, et al: Effects of genetic polymorphism on ex vivo and in vivo function of beta2-adrenoceptors in asthmatic patients. Chest 1999;115:324-328. (III)
185. 2-agonist therapy in asthma. Eur Respir J 1998;11:589-593. (IIa)
186. 2-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000;162:75-80. (IIa)
187. Lane SJ, Arm JP, Staynov DZ, et al: Chemical mutational analysis of the
188. Christodoulopoulos P, Leung DY, Elliott MW, et al: Increased number of glucocorticoid receptor-β-expressing cells in the airways in fatal asthma. J Allergy CHn Immunol 2000;106:479-484. (NC)
189. Huizenga NA, Koper JW, De Lange P, et al: A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 1998;83:144-151. (NC)
190. Di Blasio AM, van Rossum EF, Maestrini S, et al: The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients. Clin Endocrinol (Oxf) 2003;59:68-74. (NC)
191. Malmstrom K, Rodriguez-Gomez G, Guerra J, et al: Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 1999;130:487-495. (NC)
192. In KH, Asano K, Beier D, et al: Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest 1997;99:1130-1137. (NC)
193. Drazen JM, Yandava CN, Dube L, et al: Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet 1999;22:168-170. (IIa)
194. Sayers I, Barton S, Rorke S, et al: Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma. Thorax 2003;58:417-424. (NC)
195. Sanak M, Simon HU, Szczeklik A: Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997;350:1599-1600. (NC)
196. Sayers I, Barton S, Rorke S, et al: Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. Clin Exp Allergy 2003;33:1103-1110. (NC)
197. Mastalerz L, Nizankowska E, Sanak M, et al: Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist. Eur J Clin Invest 2002;32:949-955. (III)
198. Thompson MD, van's Gravesande KS, Galczenski H, et al: A cysteinyl leukotriene 2 receptor variant is associated with atopy in the population of Tristan da Cunha. Pharmacogenetics 2003:13:641-649. (III)
199. Asano K, Shiomi T, Hasegawa N, et al: Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma. Pharmacogenetics 2002;12:565-570. (IIa)